| Study | Number of cases | Control regimen | Chemo times | TCM intervention | TCM duration (days) | HCC staging | Child-Pugh score | KPS score | Randomized method | Treatment | Control |
| Huang et al. 2001 [20] | 32 | 30 | Palliatively supporting therapy | None | Jianpi Xiaoji oral liquid | 30 | III, IV | A, B, C | ≥60 | Random number table | Huang et al. 2009 [21] | 40 | 37 | TACE | 1~2 | Ganji decoction | 28~42 | II, III | A, B | ≥60 | Random number table | Li et al. 2008 [22] | 50 | 46 | TACE | 2~7 | Chinese toad bufotoxin injection | 28~112 | OkudaI, II, III | A, B | ≥60 | Sealed envelopes | Li et al. 2013 [23] | 31 | 22 | TACE | 3 | Hydroxycamptothecin and Chinese herbal compound | 84 | II, III | NA | NA | Random number table | Li et al. 2016 [24] | 26 | 26 | TACE | NA | Aidi injection | 30 | III, IV | NA | 30~60 | Random number table | Lin et al. 2005 [25] | 52 | 33 | TACE | 2 | Hydroxycamptothecin and Shentao Ruangan pill | 56 | II, III | A, B | ≥60 | Randomized block | Ling et al. 2001 [26] | 162 | 151 | TACE/PEI | NA | Sisheng decoction/Chinese toad bufotoxin injection/norcantharidin tablets | Irregular | II, III | NA | NA | Sealed envelopes | Liu 2011 [27] | 32 | 30 | Palliatively supporting therapy | None | Chinese herbal compound | 21 | III, IV | A, B, C | ≥60 | Random number table | Liu and Lü 2016 [28] | 53 | 53 | TACE + PMCT | 3 | Chinese herbal compound | 90~135 | NA | A, B | NA | Random number table | Lu 2008 [29] | 69 | 69 | TACE | NA | Aidi injection | 20 | NA | NA | 60~90 | Draw method | Lü et al. 2014 [30] | 63 | 63 | TACE | NA | Shenyi capsules | 60 | NA | NA | 60~90 | Random number table | Min and Zhou 2011 [31] | 23 | 22 | Palliatively supporting therapy | None | Chinese herbal compound | 84 | II, III | A, B | 72 ± 8 | Random number table | Ren and Cheng 2004 [32] | 104 | 68 | TACE | NA | Chinese herbal compound | ≥90 | II, III | NA | NA | Random number table | Shao et al. 2001 [33] | 30 | 30 | TACE | 2~10 | Chinese herbal compound | 180~300 | II, III | NA | NA | According to hospitalized date | Shi and Tang 2013 [34] | 42 | 56 | TACE | NA | Kang’ai injection and Carapacis Trionycis Bolus | 56 | NA | A, B | ≥60 | Random number table | Tian et al. 2008 [35] | 49 | 48 | TACE | NA | Chinese herbal compound | 28 | II, III | A, B | ≥60 | Randomized block, single blind | Xie et al. 2014 [36] | 34 | 34 | TACE | NA | Chinese herbal compound | 40 | NA | A, B | ≥60 | Draw method | Yang et al. 2011 [37] | 30 | 30 | TACE | NA | Aidi injection | 30 | NA | A, B, C | ≥70 | Sealed envelopes | Yi et al. 2008 [38] | 28 | 23 | TACE | 3 | Kang’ai injection | 45 | II, III | NA | ≥60 | Sealed envelopes | Zhong et al. 2014 [39] | 60 | 60 | Hepatectomy | None | Chinese herbal compound | 365 | I~IIIa | A, B | NA | Sealed envelopes |
|
|